To include your compound in the COVID-19 Resource Center, submit it here.

ASM 981 pimecrolimus: Phase III

Interim data from an international trial of ASM 981 cream in 700 patients 1-17

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE